DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 160 full-time employees. The company went IPO on 2013-03-08. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Mr. Erez Raphael is the Chief Executive Officer of DarioHealth Corp, joining the firm since 2013.
What is the price performance of DRIO stock?
The current price of DRIO is $7.16, it has increased 3.31% in the last trading day.
What are the primary business themes or industries for DarioHealth Corp?
DarioHealth Corp belongs to Health Care industry and the sector is Health Care
What is DarioHealth Corp market cap?
DarioHealth Corp's current market cap is $52.3M
Is DarioHealth Corp a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for DarioHealth Corp, including 3 strong buy, 5 buy, 2 hold, 0 sell, and 3 strong sell